<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728137/bin/RJME-61-1-175-fig2.jpg"/> </div> <div class="text-side"> <h1>Immunophenotypical alterations with impact on the epithelial-mesenchymal transition (EMT) process in salivary gland adenoid cystic carcinomas.</h1> <p>E-cadherin reactivity in salivary ACC: (A) The most reactive specimens were those from the patients with salivary ACC tubular subtype; (B) The subcellular pattern reactivity it was in almost equal proportions both membranous and cytoplasmic; (C) An intermediate reactivity was recorded in salivary ACC cases of solid type; (D) The reactivity was heterogeneous with areas with intense reactivity alternating with weak reactive areas; (E) The lowest reactivity was observed in the cases of salivary ACC of cribriform type; (F) The reactivity was most obvious in the neoplastic cells from the thickness of the neoplastic cords. Anti-E-cadherin antibody immunomarking: (A, C and E) ×100; (B) ×400; (D and F) ×600. ACC: Adenoid cystic carcinoma.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32747909/" target="_blank">32747909</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>